Cyclo Therapeutics Inc (CYTHW)
NASDAQ
The current CYTHW market cap is 4.09M. The company's latest EPS is USD -0.8823 and P/E is -0.79.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 118k | 495k | 311k | 202k | 124k |
Operating Income | -4.63M | -4.77M | -5.64M | -5.11M | -5.64M |
Net Income | -4.63M | -4.77M | -5.64M | -4.34M | -5.98M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.01M | 903k | 1.59M | 1.38M | 1.08M |
Operating Income | -7.39M | -8.96M | -14.27M | -15.62M | -20.05M |
Net Income | -7.53M | -8.94M | -14.29M | -15.45M | -20.06M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 4.64M | 5.6M | 13.25M | 7.16M | 4.72M |
Total Liabilities | 6.13M | 6.65M | 8.49M | 6.55M | 9.84M |
Total Equity | -1.49M | -1.05M | 4.76M | 610k | -5.12M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 4.11M | 14.19M | 19.52M | 4.22M | 13.25M |
Total Liabilities | 3.18M | 3.74M | 3.85M | 3.48M | 8.49M |
Total Equity | 936k | 10.45M | 15.67M | 734k | 4.76M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -7.85M | -11.89M | -16.18M | -6.18M | -10.03M |
Investing | N/A | N/A | -2k | N/A | N/A |
Financing | 7.15M | 12.15M | 23.89M | -69k | 1.91M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -6.59M | -8.54M | -15.01M | -15.12M | -16.18M |
Investing | 36k | -14k | 14k | 38k | -2k |
Financing | 7.12M | 18.62M | 18.76M | 7k | 23.89M |
Market Cap | 4.09M |
Price to Earnings Ratio | -0.79 |
Price to Sales Ratio | 14.8 |
Price to Cash Ratio | 1.72 |
Price to Book Ratio | 3.35 |
Dividend Yield | - |
Shares Outstanding | 22.73M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.17 (66%) |
Company Name | Cyclo Therapeutics Inc |
Address |
6714 nw 16th street gainesville, florida 32653 |
Website | https://www.cyclotherapeutics.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.